Avidity Partners Management LP lessened its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals […]
Johnson Investment Counsel Inc. Decreases Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
StockNews.com Lowers Jazz Pharmaceuticals (NASDAQ:JAZZ) to Buy themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) from a strong-buy rating to a buy rating in a report issued on Thursday morning. Other analysts have also issued reports about the stock. Cantor Fitzgerald reiterated an overweight rating and issued a $180.00 price target on shares of Jazz Pharmaceuticals in a research report […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price target dropped by equities research analysts at Barclays from $230.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 82.08% […]